CDX
Cardiex Limited
🇦🇺 ASX
🩺 HEALTH CARE
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-13.79%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
6
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
CardieX Ltd. engages in designing, manufacturing, and marketing medical devices used in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The firm develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. The company specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Company’s SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.
📈 Performance
Price History
-90.44%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.09
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in CDX
6
📊 Total Capital Earnings
$5K
🔃 Average investment frequency
22 weeks
💵 Average investment amount
$804
⏰ Last time a customer invested in CDX
30 days
CDX investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
38%
50k - 100k
25%
Less than 50k
38%
👶 Age of investors
18 - 25
26 - 34
50%
35 - 90
50%
🙋 Legal gender of investors
Female
67%
Male
33%
Pearlers who invest in CDX also invest in...
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
14.02%
📊 Share price
$140.20 AUD
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
🌏 GLOBAL
🤖 TECHNOLOGY
CDXNC
CardieX Ltd. engages in designing, manufacturing, and marketing medical devices used in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The company is engaged in designing, manufacturing, and marketing medical devices for use in cardiovascular health management, and the development of clinical and consumer digital health solutions. The company is focused on hypertension, cardiovascular disease, and other vascular health disorders. The company operates through its subsidiaries, including ATCOR and CONNEQT. ATCOR division provides medical devices for measuring arterial stiffness and central blood pressure waveforms based on its SphygmoCor technology. Under the ATCOR.X brand, it also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. Its digital platform, ArtyNet, is a connected software as a service ecosystem providing physicians with a telehealth solution for remotely managing patients’ health. CONNEQT develops and markets consumer wearable and home health devices focused on heart health and its patented fitness parameters.
🩺 HEALTH CARE
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.79%
📊 Share price
$68.90 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.62%
📊 Share price
$102.10 AUD
🇦🇺 AUSTRALIA
⛳️ DIVERSIFIED
🧱 MATERIALS
💸 FINANCIALS
Want more shares? Try these...
Coast Entertainment Holdings Ltd. engages in the investment and operation of leisure and entertainment businesses. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2018-11-30. The firm's theme parks and attractions business include Dreamworld and WhiteWater World in Coomera, Queensland and the SkyPoint observation deck and climb in Surfers Paradise, Queensland. The firm's rides and attractions include Dreamworld, WhiteWater World, Entertainment, Wildlife, Rivertown, King Claw, Kenny & Belinda's Dreamland, and Ride Status and Info. Its Dreamworld offers thrill rides, family rides, kids rides and ride express. Its WhiteWater World include Thrill slides, family slides, kids slides, Cabanas, and ride and slide express. SkyPoint offers panoramic views of the Gold Coast, Australia's external building climb, and events, located atop the iconic Q1 building in Surfers Paradise. SkyPoint Bistro+Bar offers buffet breakfast, all-day dining and signature cocktails. Its drink menu includes sparkling, rose, white, red, and milkshakes.
🙌 Performance (5Yr p.a)
-12.28%
📊 Share price
$0.49 AUD
🏨 HOTELS, RESTAURANTS & LEISURE
Castle Minerals Ltd. engages in the exploration of mineral properties in Ghana, West Africa. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-05-02. The firm has interests in several projects in Ghana and Western Australia that are prospective for battery metals (graphite and lithium), base metals (zinc, lead, and copper) and gold. In Ghana, West Africa, the emerging flagship Kambale Graphite Project is owned by its Ghanaian subsidiary, Kambale Graphite Limited. Its Ghanaian subsidiary, Carlie Mining Ltd, holds a 2,686 square kilometers tenure position in the same Upper West region. Its projects in Western Australia include Earaheedy Basin project, Beasley Creek project, Polelle project, Wilgee Springs project, and Woodcutters project. The Earaheedy Basin project comprises the Withnell and Terra Rossa sub-projects. The Beasley Creek project is prospective for gold and lithium and lies on the northern flanks of the Rocklea Dome in the southern Pilbara. The Polelle project, about seven kilometers southeast of the operating Bluebird gold mine near Meekatharra.
🙌 Performance (5Yr p.a)
-15.56%
📊 Share price
$0.00 AUD
⛏️ MINING
